Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Sinaloa Cartel Leader Ovidio Guzmán Pleads Guilty to Drug Trafficking in U.S. Court 1% U.S. Tax on Remittances Could Slash Mexican Household Spending by 25%, ANPEC Warns CIBanco, Intercam, and Vector Granted Temporary Reprieve from U.S. Sanctions San Miguel de Allende Named ‘Best City in the World’ Once Again by Travel + Leisure US Sanctions on CIBanco, Intercam Have Disrupted Clients’ Finances
